Current financial headlines

Sharemaestro Newsreel

Financial news from across the world, newest first. Choose a country or market group, open the source, or continue into the company data.

Showing
1–36
Headlines
48
Sources here
1
Companies here
8
Current section Mexico Medical Devices news
Latest

finance.yahoo.com Earnings

How GE HealthCare’s New AI Ultrasound Launches Could Shape GEHC’s Diagnostic Edge for Investors

Earlier this month, GE HealthCare introduced the LOGIQ e Xi and LOGIQ e Si laptop ultrasound systems and launched the Invenia ABUS Prime and ABUS StreamVue breast imaging solutions, expanding its AI-enabled and cloud-connected ultrasound portfolio across multiple care settings. These product launches aim to standardize imaging workflows, support remote reading, and address dense-breast screening needs, potentially strengthening …

Can Stryker's Q2 Recovery and Guidance Support a Stronger Second Half?

Stryker Corporation SYK entered the second half of 2026 with momentum restored after the March cybersecurity disruption. Second-quarter sales, earnings and margins improved as production recovered, while management narrowed its full-year outlook. The next test is execution. Stryker must keep normalizing production, convert elevated …

SYK main company
Sharemaestro market context Price below Trend Line 52 weeks -19.4% · Next-week setup negative 43.7% SYK stored weekly price path from 15 Aug 2025 to 7 Aug 2026

Stryker Up 13.6% in 3 Months as Recovery Gains Strength, What's Next?

Stryker Corporation SYK shares have risen 13.6% in the past three months, outpacing the Zacks Medical sector's 12.9% gain and the S&P 500's 1.7% advance. The move has coincided with a sharper operating recovery after a difficult first quarter. The investor question is whether …

SYK main company
Sharemaestro market context Price below Trend Line 52 weeks -19.4% · Next-week setup negative 43.7% SYK stored weekly price path from 15 Aug 2025 to 7 Aug 2026

Chronological news

Latest headlines

External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.

Here's Why Pediatrix Medical Can Be a Smart Addition to Your Portfolio

Pediatrix Medical Group, Inc. MD is a physician services provider company that offers a range of services across various specialties, including obstetrics, maternal-fetal medicine and neonatology, complemented by multiple pediatric subspecialties. The company has gained 23.9% in the year-to-date period, outperforming the industry's 1.2% …

GMED main company
Sharemaestro market context Price below Trend Line 52 weeks +40.2% · Next-week setup negative 10.2% GMED stored weekly price path from 15 Aug 2025 to 7 Aug 2026

GEHC or LMAT: Which Is the Better Value Stock Right Now?

Investors interested in Medical - Products stocks are likely familiar with GE HealthCare Technologies (GEHC) and LeMaitre Vascular (LMAT). But which of these two stocks presents investors with the better value opportunity right now? Let's take a closer look. There are plenty of strategies …

GEHC main company
Sharemaestro market context Price below Trend Line 52 weeks -11.3% GEHC stored weekly price path from 15 Aug 2025 to 7 Aug 2026

Revvity Launches SuperFlex Prenatal Screening System for Smaller Labs

Revvity, Inc. RVTY recently announced the launch of the SuperFlex prenatal screening system, a compact, CE-IVDR-certified automated immunoassay instrument designed to expand access to prenatal and preeclampsia testing. Purpose-built for small to mid-sized laboratories and clinics, the platform is intended to bring reliable, rapid …

GMED mentioned
Sharemaestro market context Price below Trend Line 52 weeks +40.2% · Next-week setup negative 10.2% GMED stored weekly price path from 15 Aug 2025 to 7 Aug 2026

Insulet Corporation’s (PODD) Wearable Pod Tech Finds New Frontier

Alpha Wealth Funds, LLC, an investment management company, released its Q2 2026 letter for the "Insiders Fund". A copy of the letter is available to download here. The Fund lost 1.45% in June, while it was up 8.43% for the 2nd quarter and 0.75% …

PODD main company
Sharemaestro market context Price below Trend Line 52 weeks -50.2% · Next-week setup negative 8.1% PODD stored weekly price path from 15 Aug 2025 to 7 Aug 2026

What's Backing Abbott's Established Pharmaceuticals Division Growth

Abbott Laboratories' ABT Established Pharmaceuticals Division ("EPD") continues to be a solid growth contributor, supported by its broad portfolio of branded generic medicines and strong commercial presence across emerging markets. In the second quarter of 2026, EPD sales increased 8.4% on a reported basis …

ABT main company
Sharemaestro market context Price above Trend Line 52 weeks -24.2% · Next-week setup negative 41.9% ABT stored weekly price path from 15 Aug 2025 to 7 Aug 2026

Wolfe Research downgrades Stryker, upgrades Abbott in med-tech shuffle

Investing.com -- Wolfe Research made two rating changes across large-cap medical devices, downgrading Stryker while upgrading Abbott Laboratories on Thursday. Analyst Mike Polark cut Stryker to Peer Perform, citing a demanding second-half setup following the company's March cyber disruption. He said the June quarter …

SYK main company
Sharemaestro market context Price below Trend Line 52 weeks -19.4% · Next-week setup negative 43.7% SYK stored weekly price path from 15 Aug 2025 to 7 Aug 2026

Revisiting Former Stock Picks Medtronic, Quantas Services, Lennar

Reassessing stock picks is one of the best habits an investor can build. Watch Doug discuss recent stock picks, provide input on the current market environment—and take your questions. The daily chart illustrates how well the stock has performed relative to its peers on …

MDTN main company
Sharemaestro market context Price below Trend Line 52 weeks -10.1% · Next-week setup negative 28.6% MDTN stored weekly price path from 15 Aug 2025 to 7 Aug 2026

Globus Medical (GMED) Stock Sees Modest Fair Value Cut As Analysts Trim Growth Views

Track your investments for FREE with Simply Wall St, the portfolio command center trusted by over 7 million individual investors worldwide. Globus Medical has seen its assessed fair value cut from US$107.42 to US$103.23, a modest 3.9% trim that reflects a cooler view on …

GMED main company
Sharemaestro market context Price below Trend Line 52 weeks +40.2% · Next-week setup negative 10.2% GMED stored weekly price path from 15 Aug 2025 to 7 Aug 2026

Is Globus Medical (GMED) A Bargain On Its Zacks Upgrade And Reaffirmed Guidance?

Track your investments for FREE with Simply Wall St, the portfolio command center trusted by over 7 million individual investors worldwide. Globus Medical (GMED) has been in focus after a recent upgrade to Zacks Rank #1, which came shortly after the company reaffirmed its …

GMED main company
Sharemaestro market context Price below Trend Line 52 weeks +40.2% · Next-week setup negative 10.2% GMED stored weekly price path from 15 Aug 2025 to 7 Aug 2026

Abbott Laboratories (ABT) Ties Lingo Glucose Data To AI Health Tools

Get insights on thousands of stocks from the global community of over 7 million individual investors at Simply Wall St. Abbott Laboratories (NYSE:ABT) and Google Health announced a multi year partnership to integrate Abbott's Lingo biowearable glucose data with Google's AI driven consumer health …

ABT main company
Sharemaestro market context Price above Trend Line 52 weeks -24.2% · Next-week setup negative 41.9% ABT stored weekly price path from 15 Aug 2025 to 7 Aug 2026

Is DXCM Stock Worth Buying as Growth Improves but Valuation Stretches?

DexCom, Inc. DXCM is entering the second half of 2026 with healthier margins, broader reimbursement and a larger continuous glucose monitoring opportunity. The investment question is whether that improving setup is enough to justify a premium valuation. Growth catalysts remain visible across U.S. coverage, …

ABT mentioned
Sharemaestro market context Price above Trend Line 52 weeks -24.2% · Next-week setup negative 41.9% ABT stored weekly price path from 15 Aug 2025 to 7 Aug 2026

DXCM Stock Up Nearly 35% YTD: Will the Uptrend Continue in the Rest of 2026?

DexCom DXCM stock has rebounded sharply in 2026, gaining 34.8% after falling 14.7% in 2025, as investors increasingly recognize the company's improving growth profile and expanding continuous glucose monitoring (CGM) opportunity. The company's share price performance so far this year has outperformed the industry's …

ABT mentioned
Sharemaestro market context Price above Trend Line 52 weeks -24.2% · Next-week setup negative 41.9% ABT stored weekly price path from 15 Aug 2025 to 7 Aug 2026

ISRG's US Procedure Growth Slows: Is ACA Headwind a Temporary Concern?

Intuitive Surgical ISRG has faced a moderation in U.S. procedure growth during the first half of 2026, but management's commentary suggests the slowdown is more likely a temporary demand-timing issue than evidence of a structural deterioration. U.S. da Vinci procedures grew 12% in the …

GMED mentioned
Sharemaestro market context Price below Trend Line 52 weeks +40.2% · Next-week setup negative 10.2% GMED stored weekly price path from 15 Aug 2025 to 7 Aug 2026

DXCM Rallies 52.5% in 3 Months. Can the Stock Keep Climbing From Here?

DexCom, Inc. DXCM shares have climbed 52.5% in the past three months, a sharp re-rating that raises the standard for further gains. The next leg depends less on momentum alone and more on whether earnings growth, margin expansion and new-market access can keep pace …

DXCM main company ABT mentioned
Sharemaestro market context Trend signal active 52 weeks -5.0% · Next-week setup negative 22.9% DXCM stored weekly price path from 15 Aug 2025 to 7 Aug 2026

Can DexCom's Raised 2026 Outlook Sustain Stronger Margin Momentum?

DexCom, Inc. DXCM raised its 2026 revenue and margin outlook after a stronger second quarter, shifting more attention toward profitability. The question is whether better gross margin and operating leverage can persist as organic growth improves. The guidance increase is encouraging, but foreign exchange, …

ABT mentioned
Sharemaestro market context Price above Trend Line 52 weeks -24.2% · Next-week setup negative 41.9% ABT stored weekly price path from 15 Aug 2025 to 7 Aug 2026

[Latest] Global Whey Protein Market Size/Share Worth USD 26.04 Billion by 2034 at a 7.56% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth, Growth Rate, Value)

Custom Market Insights [220+ Pages Latest Report] According to a market research study published by Custom Market Insights, the demand analysis of Global Whey Protein Market size & share revenue was valued at approximately USD 12.58 Billion in 2024 and is expected to reach …

ABT mentioned
Sharemaestro market context Price above Trend Line 52 weeks -24.2% · Next-week setup negative 41.9% ABT stored weekly price path from 15 Aug 2025 to 7 Aug 2026

Two Years Of Growth Barely Change What You Pay For Intuitive Surgical

Photo by 127071 on Pixabay Consensus growth takes only a modest slice off the multiple, and the company has not yet set the instrument pricing that lands inside those two years. Intuitive Surgical (ISRG) trades at about $401.23, roughly 32% below its 52-week high …

GMED mentioned
Sharemaestro market context Price below Trend Line 52 weeks +40.2% · Next-week setup negative 10.2% GMED stored weekly price path from 15 Aug 2025 to 7 Aug 2026

GE HealthCare (GEHC) Upgraded to Buy: Here's What You Should Know

GE HealthCare Technologies (GEHC) appears an attractive pick, as it has been recently upgraded to a Zacks Rank #2 (Buy). This upgrade is essentially a reflection of an upward trend in earnings estimates -- one of the most powerful forces impacting stock prices. A …

GEHC main company
Sharemaestro market context Price below Trend Line 52 weeks -11.3% GEHC stored weekly price path from 15 Aug 2025 to 7 Aug 2026

Here's Why You Should Add BrightSpring Stock to Your Portfolio Now

BrightSpring Health Services, Inc. BTSG is well-poised for growth in the coming quarters, backed by strong momentum in Provider Services, expanding specialty and infusion operations, successful integration of acquired home health assets and a scalable home-based care platform. However, the Inflation Reduction Act (IRA)-related …

GMED mentioned
Sharemaestro market context Price below Trend Line 52 weeks +40.2% · Next-week setup negative 10.2% GMED stored weekly price path from 15 Aug 2025 to 7 Aug 2026

NPCE Q2 Earnings Beat Estimates on RNS Growth, '26 Revenue View Up

NeuroPace, Inc. NPCE reported a second-quarter 2026 loss per share of 18 cents, compared with a loss of 30 cents in the year-ago period. The figure beat the Zacks Consensus Estimate by 5.3%. Shares of NPCE were down approximately 2.3% during after-market trading following …

GMED mentioned
Sharemaestro market context Price below Trend Line 52 weeks +40.2% · Next-week setup negative 10.2% GMED stored weekly price path from 15 Aug 2025 to 7 Aug 2026

Abbott and Big Ten bring back 'We Give Blood' as U.S. faces blood supply crisis

"We Give Blood" brings together all 18 Big Ten® schools in a competition to drive the most blood donations and win $1 million from global healthcare company Abbott For only the second time in its history, the American Red Cross has declared a national …

ABT main company
Sharemaestro market context Price above Trend Line 52 weeks -24.2% · Next-week setup negative 41.9% ABT stored weekly price path from 15 Aug 2025 to 7 Aug 2026

Does Medtronic (MDT) Still Trade At A Discount After Its CE Mark Win?

Find your next quality investment with Simply Wall St's easy and powerful screener, trusted by over 7 million individual investors worldwide. Medtronic stock has delivered a 20.8% gain over the past three years, yet current checks suggest it now sits close to its estimated …

MDTN main company
Sharemaestro market context Price below Trend Line 52 weeks -10.1% · Next-week setup negative 28.6% MDTN stored weekly price path from 15 Aug 2025 to 7 Aug 2026

Stryker’s (SYK) Comeback Quarter Looks Great, But At What Cost?

Stryker (NYSE:SYK) turned in one of its stronger quarters in recent memory on July 30, with sales climbing 9.4% to $6.6 billion and reported EPS jumping 44.1% to $3.30. The numbers arrive as the company works its way back from a cyber incident that …

SYK main company
Sharemaestro market context Price below Trend Line 52 weeks -19.4% · Next-week setup negative 43.7% SYK stored weekly price path from 15 Aug 2025 to 7 Aug 2026

Medtronic (MDT) Wins Analyst Upgrades, Is It Fully Priced?

Find your next quality investment with Simply Wall St's easy and powerful screener, trusted by over 7 million individual investors worldwide. Medtronic (MDT) has moved back into focus after multiple analyst upgrades tied to what they describe as the company's strongest annual revenue growth …

MDTN main company
Sharemaestro market context Price below Trend Line 52 weeks -10.1% · Next-week setup negative 28.6% MDTN stored weekly price path from 15 Aug 2025 to 7 Aug 2026

Arrow Exploration confirms four zones at Icaco 3, opens up ~10 new drilling locations

Arrow Exploration Corp (TSX-V:AXL, AIM:AXL, OTC:CSTPF) CEO Marshall Abbott tells Proactive's Stephen Gunnion that the Icaco 3 well has confirmed up to four hydrocarbon-bearing zones in the Icaco extension of the Tapir Block in Colombia, opening almost 10 additional development locations across the Ubaque, …

ABT mentioned
Sharemaestro market context Price above Trend Line 52 weeks -24.2% · Next-week setup negative 41.9% ABT stored weekly price path from 15 Aug 2025 to 7 Aug 2026

CAH Q4 Earnings Beat on Pharma Strength, Revenues Miss, Stock Up

Cardinal Health, Inc. CAH reported fourth-quarter fiscal 2026 adjusted earnings per share (EPS) of $2.91, beating the Zacks Consensus Estimate by 20.3%. The bottom line improved 40% year over year, aided by higher operating earnings, IEEPA tariff refunds, a lower tax rate and a …

GMED mentioned
Sharemaestro market context Price below Trend Line 52 weeks +40.2% · Next-week setup negative 10.2% GMED stored weekly price path from 15 Aug 2025 to 7 Aug 2026

Globus Medical (GMED) Upgraded to Strong Buy: Here's Why

Globus Medical (GMED) could be a solid addition to your portfolio given its recent upgrade to a Zacks Rank #1 (Strong Buy). This rating change essentially reflects an upward trend in earnings estimates -- one of the most powerful forces impacting stock prices. The …

GMED main company
Sharemaestro market context Price below Trend Line 52 weeks +40.2% · Next-week setup negative 10.2% GMED stored weekly price path from 15 Aug 2025 to 7 Aug 2026

GMED vs. ITGR: Which Stock Is the Better Value Option?

Investors interested in Medical - Instruments stocks are likely familiar with Globus Medical (GMED) and Integer (ITGR). But which of these two stocks is more attractive to value investors? We'll need to take a closer look to find out. Everyone has their own methods …

GMED main company
Sharemaestro market context Price below Trend Line 52 weeks +40.2% · Next-week setup negative 10.2% GMED stored weekly price path from 15 Aug 2025 to 7 Aug 2026

GE HealthCare Technologies (GEHC) Just Overtook the 200-Day Moving Average

GE HealthCare Technologies (GEHC) reached a significant support level, and could be a good pick for investors from a technical perspective. Recently, GEHC broke through the 200-day moving average, which suggests a long-term bullish trend. The 200-day simple moving average helps traders and analysts …

GEHC main company
Sharemaestro market context Price below Trend Line 52 weeks -11.3% GEHC stored weekly price path from 15 Aug 2025 to 7 Aug 2026

Abbott and Google launch first-of-its-kind partnership to transform everyday health through glucose insights and AI

Multi-year collaboration combines ongoing glucose insights from Abbott's Lingo biowearable with Google Health's technology to create a more comprehensive view of personal health Partnership includes a large-scale research study to better inform artificial intelligence (AI) coaching available in the Google Health app and future …

ABT main company
Sharemaestro market context Price above Trend Line 52 weeks -24.2% · Next-week setup negative 41.9% ABT stored weekly price path from 15 Aug 2025 to 7 Aug 2026

Abbott vs. Medtronic: Is Consistent Growth Better Than a Turnaround Story?

Abbott Laboratories (NYSE:ABT) and Medtronic (NYSE:MDT) are both prominent names in the Medtech space. Abbott Laboratories (NYSE:ABT) delivered strong fiscal Q2 2026 results, beating quarterly estimates and raising its annual profit forecast as robust demand for its cancer diagnostics and medical devices businesses helped …

ABT main company
Sharemaestro market context Price above Trend Line 52 weeks -24.2% · Next-week setup negative 41.9% ABT stored weekly price path from 15 Aug 2025 to 7 Aug 2026

Johnson & Johnson vs Abbott Laboratories: Which Healthcare Giant Offers the More Compelling Growth Story After Earnings?

Johnson & Johnson (NYSE:JNJ) delivered strong fiscal Q2 2026 results, with sales for the quarter growing nearly 7% to $25.31 ⁠billion, above analysts' average estimate of about $25.05 billion. Adjusted earnings per share reached $2.90, surpassing the expectation of $2.85. The company also raised …

ABT mentioned
Sharemaestro market context Price above Trend Line 52 weeks -24.2% · Next-week setup negative 41.9% ABT stored weekly price path from 15 Aug 2025 to 7 Aug 2026

Boston Scientific CEO Mahoney Buys More Than 200k Shares for $10 Million. What Does This Mean for Investors in 2026?

Michael F. Mahoney, Chairman, President & CEO of Boston Scientific Corporation (NYSE:BSX), purchased 186,240 shares of common stock at $48.34 per share on August 3, 2026. SEC Form 4 filing. Transaction summary Metric Value Transaction value $10.1 million Shares purchased 208,359 Post-transaction shares (total) …

BSX main company
Sharemaestro market context Price below Trend Line 52 weeks -56.2% · Next-week setup negative 43.0% BSX stored weekly price path from 15 Aug 2025 to 7 Aug 2026

Find financial news

Search the Newsreel

Use one field or combine several. Results are newest first.

Evidence context